Tag: inspection

Analysis of an Unapproved Change in Process Parameters During a Commercial Campaign In the landscape of pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practices (GMP) is crucial to ensure product…

Analysis of an Unapproved Process Parameter Change in Inspection Readiness In a recent scenario at a biopharmaceutical manufacturing facility, an unapproved change to a process parameter was discovered during preparations…

Exploring Unapproved Process Parameter Changes During Inspection Readiness and CAPA Outcomes A large pharmaceutical manufacturing facility recently faced a significant challenge leading to substantial operational disruptions and heightened scrutiny during…

“`html Understanding Unplanned Delays in Inspection Prep: A Root Cause Case Study In a recent scenario at a biotech manufacturing facility, an unplanned hold time extension was observed during the…

Investigation into Unplanned Hold Time Extensions During Inspection Preparations In the highly regulated pharmaceutical industry, any deviation from established protocols can lead to significant regulatory scrutiny. This case study details…

Case Study on Equipment Utilization Without Release in Routine Pharmaceutical Manufacturing In the landscape of pharmaceutical manufacturing, strict adherence to regulatory guidelines is imperative, especially when it comes to the…

Case Study: Regulatory Impact Assessment of a Batch Executed with an Expired SOP in a Commercial Campaign In an environment where precision is paramount, the execution of a batch under…

Lessons Learned from a Critical IPC Skipped During Routine Manufacturing The pharmaceutical manufacturing process is intricate and tightly regulated, where a minor deviation can lead to significant consequences. This case…

Analysis of Unapproved Process Parameter Changes During Tech Transfer The pharmaceutical industry is governed by strict regulatory standards to ensure product safety and efficacy. However, deviations can occur, leading to…

Investigation of Skipped Critical IPC During Changeover: Insights from a Regulatory Impact Assessment In the world of pharmaceutical manufacturing, adherence to standardized operating procedures (SOPs) is paramount. This case study…

Investigation of a Deviation Closed without Effectiveness Check During Changeover In the pharmaceutical manufacturing sector, ensuring compliance with Good Manufacturing Practices (GMP) is paramount. An unresolved deviation during a critical…

Breakdown of FDA Inspection Observations Regarding Equipment Used Without Release During Changeover In the ever-vigilant arena of pharmaceutical manufacturing, regulatory compliance is paramount. A recent FDA inspection highlighted a significant…